đź“… CATALYST REMINDER | $LRMR
October 26, 2026 (estimated, not confirmed) — Phase 3 Trial Start
Phase 3 FORWARD-FA start (nomlabofusp, Friedreich's ataxia). Rolling BLA: 2H 2026 window.
đź”— Full details: www.merlintrader.com/larimar-ther...
#LRMR #Biotech #FriedreichsAtaxia
